1,375 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
PFE Pfizer, Inc. $36.94 $220.19B Uptrend
Healthcare ETFs to Watch As Q4 Earnings Unfold http://www.zacks.com/stock/news/289617/healthcare-etfs-to-watch-as-q4-earnings-unfold?cid=CS-ZC-FT-289617 Jan 22, 2018 - With earnings surprises well in the cards, the healthcare sector is expected to witness earnings growth of 3% in the fourth quarter, suggesting some upside for healthcare ETFs.
Whom Will Pfizer Buy in 2018? https://www.fool.com/investing/2018/01/22/whom-will-pfizer-buy-in-2018.aspx?source=iedfolrf0000001 Jan 22, 2018 - Keep your eyes on these three drugmakers.
The Ideal Stock Evaluation System? https://seekingalpha.com/article/4139043-ideal-stock-evaluation-system?source=feed_tag_editors_picks Jan 22, 2018 - Reviews five stock evaluation systems.Offers a potential alternative and outlines its advantages.Demonstrates, through backtests, its effectiveness.Names the stocks it favors today.
Merck Reports Positive Phase III Liver Cancer Data on Keytruda http://www.zacks.com/stock/news/289616/merck-reports-positive-phase-iii-liver-cancer-data-on-keytruda?cid=CS-ZC-FT-289616 Jan 22, 2018 - Merck (MRK), announces first time results from the phase II study evaluating the use Keytruda in patients with advanced hepatocellular carcinoma (HCC), previously treated with sorafenib.
Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc. https://www.fool.com/investing/2018/01/21/better-buy-gilead-sciences-inc-vs-pfizer-inc.aspx?source=iedfolrf0000001 Jan 21, 2018 - Which stock wins in a head-to-head match-up between the big biotech and the big pharma company?
3 Things In Biotech You Should Learn Today: January 20, 2018 https://seekingalpha.com/article/4138941-3-things-biotech-learn-today-january-20-2018?source=feed_sector_healthcare Jan 21, 2018 - Olaparib is finally approved in Japan as maintenance.Merck and Macrogenics look to salvage hopes of pembro in gastric cancer.Pfizer and Gilead mark a big CAR-T cell collab.
How to use your investments to support women in the workplace https://www.cnbc.com/2018/01/21/investment-strategies-focus-on-supporting-women-in-the-workplace.html Jan 21, 2018 - If you want to support women in the workplace, the right portfolio strategy can back that up.
Pfizer: The Best Big Pharma Dividend Stock https://seekingalpha.com/article/4138894-pfizer-best-big-pharma-dividend-stock?source=feed_sector_healthcare Jan 21, 2018 - Strong free cash flow allows Pfizer to return a significant amount of capital back to shareholders through dividends (3.66% annual yield) and share repurchases.Pfizer's stock trades at a discount base
3 Things In Biotech You Should Learn Today: January 19, 2018 https://seekingalpha.com/article/4138815-3-things-biotech-learn-today-january-19-2018?source=feed_sector_healthcare Jan 20, 2018 - Amgen stacks the deck on multiple myeloma.Pfizer and Foundation Medicine partner up for companion diagnostics.Novartis on the precipice of another biosimilar approval.
Gilead Collaborates with Pfizer for Yescarta Combo Study http://www.zacks.com/stock/news/289507/gilead-collaborates-with-pfizer-for-yescarta-combo-study?cid=CS-ZC-FT-289507 Jan 19, 2018 - Kite, a Gilead Company (GILD), announced that it inked a clinical trial collaboration with Pfizer, for combination study.

Pages: 123456...138

Page 1>

Related Companies

Name Exchange Price Mkt Cap
TIG TiGenix NASDAQ $41.94 $231.19B
NVS Novartis AG NYSE $86.94 $203.69B
ABBV AbbVie Inc. NYSE $104.64 $167.05B
MRK Merck & Company, Inc. NYSE $61.28 $166.95B
NVO Novo Nordisk A/S NYSE $57.79 $141.14B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Pfizer
PFE - Google Finance https://www.google.com/finance?q=PFE Industry related info and international coverage Summary News
PFE - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=PFE Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options